Shanghai,, September 30, 2025 / Prnewswire / – From September 24 to 26, Innoval Technology Co., Ltd. (Innovax Medtech) presented its portfolio of proprietary products at 2025 Medtec China, covering medical imaging and respiratory care. Among them, there was the portable mesh nebulizer owner of the company, alongside a portable oxygen concentrator, an AI sleeping assistance system, injection and glucose-blood glucose pens, aroused strong interest in health care and medtechs.
“Our product portfolio spans Several Key Healthcare Segments-in in -vitro diagnostics and medical imaging to respiratory care, smart rehabilitation, and wearable health devices,” Said Jackson Shih, Chairman of Innovax Medtech, During A Live Interview On September 25. CDMO (Contract Development and Manufacturing Organization), Innovax MEDTECH PROVIDES END-TO-END, Precision Development and Manufacturing Services for Medical Devices Global Customers.
Shih noted that if the CDMO model is well established in Europe and the United States, most national companies are still focusing on components transformation, with only a limited number capable of providing end-to-end services from the design to the manufacturing of the final product. “From design to an early stage and from R&D to commercial manufacturing, startups often encounter various obstacles, in particular financing, technology and resource constraints, which makes it difficult to manage the full development course at market entry independently. And obstacles to execution.”
For its CDMO partners, the protection of intellectual property is an absolute priority. Asked about the company’s confidentiality approach, Shih explained that Innomax Medtech has established a complete confidentiality program and technical guarantees covering four key areas: institutional protocols, information security measures, process controls and personnel management. Together, these measures offer layers protection with preventive controls, real-time monitoring and post-invitation traceability, to protect customer data and preserve technological exclusivity.
In recent years, the global CDMO market has maintained strong growth. China has become a key participant in this sector, increasingly taking externalized world production by relying on its cost savings, its strong manufacturing foundations and its technical capacities. “Innovax Medtech has the capacity to provide fully integrated medical devices solutions,” said Shih. “For the future, we will continue to deepen our expertise, expand our global footprint and strengthen our international service capacities. Our goal is to provide customers with more efficient and end-to-end solutions, to create a platform for manufacturing world, open and sustainable medical devices.”
Show original content to download the multimedia:https://www.prnewswire.com/apac/news-releases/innomax-medtech-chairman-jackson-shih-bridging-technical-gaps-with-end-to-service
Source Innovax Medtech
